Lung Stent Market Size & Growth Forecast 2027–2036, By Segments (Device Type, Patient, Product, Material, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Lung Stent Market size was worth USD 190.1 million in 2026 and is expected to grow at a 10.07% CAGR between 2027 and 2036, attaining USD 496.22 million by 2036. The industry revenue for 2027 is assessed at USD 206.35 million.
Get more details on this report
Request Free Sample ReportLung Stent Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through advanced healthcare infrastructure, experienced specialists, established reimbursement systems, and widespread access to minimally invasive respiratory interventions.
- Asia Pacific is expanding rapidly as respiratory disease burden rises, healthcare infrastructure improves, and hospitals invest in advanced equipment, specialized facilities, and trained professionals.
Segment Momentum
- Self-expandable devices represent the largest and fastest-growing device type, supported by their ability to adapt to airway anatomy and maintain airway patency. Improved designs and delivery systems are strengthening their suitability for minimally invasive airway interventions.
- Tracheal stents represent the largest and fastest-growing product segment, helping maintain airflow in patients with airway obstruction, stenosis, compression, or structural abnormalities. Advances in flexibility, deployment systems, and materials are expanding their clinical applicability.
Market Expansion Drivers
- Rising Prevalence of Chronic Lung Diseases.
- Technological Advancements in Stent Design & Materials.
- Adoption of Minimally Invasive Lung Stent Procedures.
Leading Market Participants
- Prominent companies in the lung stent market include Boston Scientific (USA), Medtronic (USA), Cook Medical (USA), MicroPort (China), Merit Medical (USA), Olympus (Japan), Edwards Lifesciences (USA), Terumo (Japan), PneumRx (USA), Endotronix (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 190.1 million
- 2027 Estimated Market Size: USD 206.35 million
- Projected Market Size: USD 496.22 million by 2036
- Growth Forecast: 10.07% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Device Type (Self-expandable) | Patient (Adult) | Product (Tracheal Stents) | Material (Metal) | End Use (Hospitals)
- Emerging Opportunity Segment: Device Type (Self-expandable) | Patient (Adult) | Product (Tracheal Stents) | Material (Silicone) | End Use (Hospitals)
Market Growth Drivers and Industry Trends
Rising Prevalence of Chronic Lung Diseases
The rising prevalence of chronic respiratory conditions is increasing the need for interventions that can help maintain airway patency and improve respiratory function. Conditions associated with airway narrowing or obstruction can require supportive procedures when conventional treatment approaches are insufficient. Growing awareness of respiratory disease management and improvements in diagnostic capabilities are contributing to earlier identification of patients who may require interventional treatment, supporting demand for lung stent procedures.
Technological Advancements in Stent Design & Materials
Technological advancements in stent design and materials are improving the range of options available for managing complex airway conditions. Innovations focused on flexibility, placement accuracy, biocompatibility, and controlled expansion are helping address anatomical and clinical requirements across different patient groups. Continued development of specialized designs and material technologies is also supporting efforts to reduce procedural complications and improve long-term airway management, strengthening the role of stents in interventional respiratory care.
Adoption of Minimally Invasive Lung Stent Procedures
The adoption of minimally invasive lung stent procedures is being supported by the clinical preference for interventions that can address airway obstruction while limiting procedural trauma. Advances in bronchoscopy and image-guided techniques have improved the ability of clinicians to access and treat affected airway regions with greater precision. Growing emphasis on shorter recovery periods, patient comfort, and targeted intervention is encouraging the use of minimally invasive approaches in appropriate cases.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising Prevalence of Chronic Lung Diseases | 3% | Short term (≤ 2 yrs) | North America; Europe | Medium | Fast |
| Technological Advancements in Stent Design & Materials | 3.3% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Adoption of Minimally Invasive Lung Stent Procedures | 3.5% | Long term (5+ yrs) | North America; Asia Pacific | Low | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share in 2026, led by advanced healthcare infrastructure, established interventional pulmonology capabilities, and widespread access to sophisticated diagnostic and therapeutic technologies. The region has a well-developed network of hospitals and specialized healthcare facilities capable of performing complex respiratory interventions, creating a strong clinical environment for the adoption of lung stents. The increasing burden of respiratory disorders and the growing need for minimally invasive treatment approaches are also contributing to demand for bronchoscopic and airway management procedures. In addition, the presence of experienced specialists, advanced imaging and bronchoscopy capabilities, and established reimbursement and healthcare delivery systems supports the utilization of lung stenting procedures. Continued improvements in minimally invasive technologies and growing emphasis on patient-centered respiratory care are further supporting market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to grow at the fastest rate, influenced by the increasing burden of respiratory diseases, improving healthcare infrastructure, and expanding access to advanced minimally invasive procedures. Growing awareness of respiratory health and the need for effective management of airway obstruction are encouraging greater utilization of specialized diagnostic and therapeutic interventions. Healthcare systems across emerging economies are also undergoing modernization, with hospitals increasingly investing in advanced equipment, specialized treatment facilities, and trained medical professionals. Rising healthcare expenditure and improving access to specialized respiratory care are creating favorable conditions for the adoption of lung stents. In addition, increasing patient access to advanced treatment options and the expansion of medical facilities in urban and developing areas are expected to support continued growth across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Interventional Pulmonary InnovationThe U.S. lung stent market emphasizes advanced airway interventions supported by specialist pulmonary and thoracic care. Commercial priorities include stent designs that improve airway patency, procedural control, placement reliability, and compatibility with evolving minimally invasive approaches for complex airway conditions.
Germany 🇩🇪
Precision Airway InterventionGermany prioritizes lung stents that provide reliable airway support within specialized interventional procedures. Healthcare providers emphasize precise placement, biocompatible materials, procedural safety, and durable performance, with purchasing decisions influenced by the ability to integrate devices into established specialist treatment workflows.
Japan 🇯🇵
Minimally Invasive Airway CareJapan's lung stent market focuses on precise airway management through minimally invasive intervention. Device priorities include compact and adaptable designs, dependable deployment, patient-specific fit, and procedural ease for specialists managing complex airway narrowing or obstruction.
South Korea 🇰🇷
Advanced Airway ProceduresSouth Korea's market emphasizes lung stents that support sophisticated interventional pulmonology procedures. Commercial priorities include deployment precision, stent flexibility, reliable airway opening, and device designs that enable specialists to manage complex cases while maintaining procedural efficiency.
France 🇫🇷
Specialist Respiratory InterventionFrance's lung stent market centers on specialist airway interventions where device reliability and patient-specific treatment are important. Providers prioritize precise deployment, appropriate stent configuration, biocompatibility, and dependable airway support across minimally invasive respiratory procedures.
Italy 🇮🇹
Airway Support SolutionsItaly's market prioritizes practical and reliable lung stent solutions for specialist respiratory procedures. Device selection focuses on placement control, adaptability to airway anatomy, procedural handling, and sustained airway support, supporting clinicians managing complex obstruction and narrowing cases.
Lung Stent Market Share (%), by Device Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDevice Type Segment Analysis: Self-expandable (Largest & Fastest-Growing Segment)
The self-expandable device type represents the largest segment in the lung stent market and is also expected to be the fastest-growing segment, supported by its ability to maintain airway patency while adapting to the anatomical characteristics of the respiratory tract. Self-expandable lung stents can be deployed with less dependence on rigid structural support and are designed to expand after placement, making them useful in managing airway narrowing and obstruction associated with various pulmonary conditions. Their flexibility and deployment characteristics can support placement in anatomically challenging airways while helping restore airflow and improve respiratory function. Continued advancements in stent design, materials, delivery systems, and clinical techniques are enhancing the usability of self-expandable devices. As clinicians seek minimally invasive approaches for maintaining airway openness and improving patient comfort, demand for self-expandable lung stents is expected to remain strong.
Patient Segment Analysis: Adult (Largest & Fastest-Growing Segment)
The adult patient segment represents the largest segment in the lung stent market and is also expected to be the fastest-growing segment, reflecting the broader use of airway stenting in adult patients experiencing malignant or benign airway obstruction, narrowing, or structural abnormalities. Adults account for a substantial proportion of conditions requiring interventional respiratory procedures, creating sustained demand for devices that can restore and maintain airway patency. The increasing use of minimally invasive bronchoscopic interventions and improvements in respiratory diagnostics are supporting earlier identification and treatment of airway complications. Advances in stent design and placement techniques are also helping clinicians address complex airway anatomies while managing treatment-related considerations. As the clinical use of airway interventions expands and healthcare providers increasingly seek effective approaches for relieving respiratory obstruction, the adult patient segment is expected to remain a central contributor to market growth.
Product Segment Analysis: Tracheal Stents (Largest & Fastest-Growing Segment)
The tracheal stents segment represents the largest segment in the lung stent market and is also expected to be the fastest-growing segment, driven by the need to maintain tracheal patency in patients affected by airway obstruction, compression, stenosis, or structural abnormalities. Tracheal stents provide mechanical support to narrowed or compromised sections of the trachea, helping restore airflow and alleviate respiratory symptoms. Their use is particularly relevant in complex airway management where conventional medical approaches may not adequately maintain an open airway. Improvements in stent architecture, flexibility, deployment systems, and material performance are supporting broader clinical applicability while helping physicians address varying airway conditions. Growing adoption of minimally invasive bronchoscopic procedures and continued advancements in interventional pulmonology are expected to reinforce demand for tracheal stents, supporting their continued importance in the lung stent market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Device Type | Self-expandable, Balloon-expandable | Self-expandable | Self-expandable |
| Patient | Adult, Pediatric | Adult | Adult |
| Product | Tracheal Stents, Bronchial Stents, Laryngeal Stents | Tracheal Stents | Tracheal Stents |
| Material | Silicone, Metal, Hybrid | Metal | Silicone |
| End Use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Hospitals |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Advancements in the lung stent market center on optimizing mechanical radial force while minimizing long-term tissue trauma within dynamic airway environments. Key structural priorities include achieving adequate vessel patency without exerting excessive pressure that triggers tissue overgrowth or restenosis. Simultaneously, delivery system precision remains paramount; intuitive, highly maneuverable deployment mechanisms allow clinicians to navigate tortuous bronchial anatomy and accurately position devices, directly reducing procedural complications and migration risks. While bioresorbable stent architectures offer promising avenues to eliminate secondary removal procedures, widespread adoption requires robust clinical validation showing predictable degradation rates and minimal tissue inflammation compared to established biocompatible metallic and silicone options.
Key companies in the lung stent market:
- Boston Scientific (USA)
- Medtronic (USA)
- Cook Medical (USA)
- MicroPort (China)
- Merit Medical (USA)
- Olympus (Japan)
- Edwards Lifesciences (USA)
- Terumo (Japan)
- PneumRx (USA)
- Endotronix (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific (USA) | |||||||
| Medtronic (USA) | |||||||
| Cook Medical (USA) | |||||||
| MicroPort (China) | |||||||
| Merit Medical (USA) | |||||||
| Olympus (Japan) | |||||||
| Edwards Lifesciences (USA) | |||||||
| Terumo (Japan) | |||||||
| PneumRx (USA) | |||||||
| Endotronix (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Everis Medical | May 2026 | Everis Medical completed its acquisition of Hood Laboratories, with Hood Laboratories subsequently operating as an Everis Medical division. The transaction adds specialized silicone airway-stent capabilities to Everis Medical’s broader airway-management portfolio, strengthening its presence across the airway-device value chain and expanding its capabilities in products relevant to the lung stent market. |
| Peytant Solutions | October 2024 | Peytant Solutions received FDA De Novo clearance for AMStent®, an amnion-covered tracheobronchial stent intended for adult malignant strictures. The regulatory decision established a Class II device category under 21 CFR 868.3721, providing a regulatory reference point for biologically surfaced airway stents and supporting commercialization of this differentiated stent technology. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Lung Stent Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Indication | Malignant Airway Obstruction, Benign Airway Obstruction, Tracheobronchomalacia, Post-Surgical Airway Complications, Fistula Management |
| Deployment Method | Bronchoscopic Deployment, Fluoroscopic Deployment, Surgical Deployment |
| Reimbursement Status | Fully Reimbursed Procedures, Partially Reimbursed Procedures, Self-Pay Procedures |
Lung Stent Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Clinical Adoption & Procedure Pathway Analysis |
|
| Reimbursement & Patient Access Landscape |
|
| Unmet Clinical Need & Indication Expansion |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market size of the lung stent market?
How is the lung stent industry projected to perform over the next decade?
How are advances in stent design influencing lung stent adoption?
Why are minimally invasive techniques becoming more important in lung stent procedures?
Why do self-expandable devices lead the lung stent market?
Why are tracheal stents gaining importance in airway management?
Why does North America lead the lung stent market?
What is driving lung stent market growth in Asia Pacific?
What are the prominent companies operating in the lung stent landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook